Clinical Trials Browser

Phase 2 × NIH × Thymoma × Clear all

NCT03076554 2026-04-07

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Phase 2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Thymoma

NCT04417660 2026-04-07

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

Phase 2 Active not recruiting

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT05104736 2026-04-07

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Phase 2 Recruiting

Thymic epithelial tumor, Peripheral Nervous System Diseases, Thymoma, Thymus Neoplasms

NCT01306045 2024-10-01

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

Phase 2 Completed

647 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma

NCT01621568 2024-09-24

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

Phase 2 Completed

56 enrolled 15 charts

Thymoma, Thymus Neoplasms

NCT01610544 2018-07-05

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Hyperplasia, Thymoma, Thymus Neoplasms

NCT00965250 2016-12-23

Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Phase 2 Completed

49 enrolled 20 charts

Thymoma

NCT00589290 2015-09-30

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Phase 2 Completed

41 enrolled 8 charts

Mediastinal Neoplasms, Thymoma

NCT00718809 2015-06-10

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Phase 2 Terminated

21 enrolled 13 charts

Thymoma